We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Collagen & Gelatin Market: Growth, Size, Share, and Trends

Report Code BT 5488
Published in Apr, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region - Global Forecast to 2030

Overview

The global collagen & gelatin market, valued at US$1203.9 million in 2024, is forecasted to grow at a robust CAGR of 5.8%, reaching US$1,295.5 million in 2025 and an impressive US$1,671.3 million by 2030. Growing incidence of diabetes, cancer, and chronic diseases; rising demand for advanced wound care products; surge in surgical procedures; increasing use in tissue engineering and regenerative medicine; extensive application of collagen as a drug delivery system are driving the market.

Collagen & Gelatin Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Collagen & Gelatin Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the presence of established and emerging players, favorable funding support for research on collagen and gelatin.

Growth in the collagen & gelatin market can mainly be attributed to the increasing number of orthopedic surgeries.

Emphasis on launch of novel products in the market and geographical expansions are key opportunity areas for players in this market.

Globally, US is the largest market for collagen and gelatin and this trend is expected to continue during the forecast period

The Asia Pacific market is estimated to witness the highest CAGR in collagen market (6.6%) during the forecast period.

Global Collagen & Gelatin Market Dynamics

DRIVER: Rising demand for advanced wound care products

The rising global incidence of chronic, surgical, and traumatic wounds drives the demand for collagen- and gelatin-based medical devices. Pressure ulcers, diabetic foot ulcers, and venous leg ulcers are becoming more common, particularly in the elderly population and in patients who are diabetic or suffer from vascular disease. For instance, diabetic foot ulcers affect more than 25% of patients with diabetes throughout their lifetime. Standard wound dressing often proves inadequate, highlighting the urgent need for newer technologies that can promote tissue regeneration and reduce the healing time. These innovative collagen dressings, such as Promogran Prisma, accelerate wound closure and reduce the risk of infection.

Collagen assists in cell migration and angiogenesis, which are vital for successfully healing a wound. Gelatin, widely used in matrices and sponges, assists in blood control and a moist wound environment, further enhancing healing success. The market is also being driven by technological innovations such as developing next-generation collagen dressings that incorporate silver for antimicrobial properties, growth factors for accelerated healing, and bioresorbable features that reduce the need for dressing changes. These high-performance products are becoming the standard in hospital and outpatient wound care in developed healthcare systems.

As patients’ needs and clinical standards evolve, the demand for effective, advanced wound care solutions using collagen and gelatin will drive this market.

RESTRAINT: High production cost of collagen

The high production cost of collagen limits its extensive commercialization in cost-sensitive applications such as drug-delivery systems and implantable medicinal devices. Collagen production requires extensive purification, origin verification, and GMP-certified manufacture, substantially escalating operation costs. For instance, purified bovine or porcine-derived collagen may cost anywhere from USD 300 to USD 800 per kilogram, whereas recombinant human collagen, applied for its high level of biocompatibility and low level of immunogenicity, may cost more than USD 1,200 per kilogram based on high-level bioengineering requirements.

DSM Biomedical, Rousselot Biomedical, and Geltor Inc. provide superior-quality collagen materials at a price that accurately represents the capital-intensive process of sourcing, processing, and testing. Moreover, increasing global energy prices and supply chain volatility further added to raw material and production costs, pinching margins at every point on the value chain. For small and medium-sized businesses, particularly in developing markets, these cost dynamics are a major entry barrier and cap the scalability of collagen-based innovations.

To address these restraints, companies can explore alternative production methods such as recombinant collagen, which, despite its higher initial production costs, offers enhanced biocompatibility and consistent quality. Innovations in synthetic biology, spearheaded by firms such as Geltor Inc., are creating engineered collagen solutions that can be tailored for specific applications, presenting a potential path to mitigate the high costs of traditional extraction methods. However, scaling these production methods remains a hurdle in achieving cost parity with conventional collagen.

 

OPPORTUNITY: Growing adoption of marine & recombinant collagen

Marine collagen, mainly sourced from fish skin, scales, and bones, provides a clean-label, environment-friendly, and culturally diverse substitute to bovine and porcine sources. For example, Nitta Gelatin’s Wellnex marine collagen is picking up pace in Japan and Southeast Asia for application in nutraceuticals and beauty supplements, mainly because of its high bioavailability and reduced risk of disease transmission or allergenicity. Vital Proteins—a Nestlé Health Science brand launched marine collagen peptide powders for pescatarian and wellness-oriented consumers in North America and Europe. This ocean-based solution complies with Halal and Kosher standards and resonates with consumers looking for traceable and ocean-conscious ingredients.

Evonik is developing fermentation-based collagen for medical devices and tissue engineering applications, where consistency, purity, and safety are critical. These advances balance out risk from zoonotic disease and immune rejection, converge with ESG goals, and make supply chains future-proof in regulatory-sensitive environments. These alternative collagens are widely used in nanoparticle formulations, injectable hydrogels, and 3D-printed scaffolds for controlled drug release. Marine collagen’s high solubility and absorption rates enhance bioavailability, particularly for peptide and protein-based drugs, while recombinant collagen can be engineered with specific functional domains (e.g., integrin-binding sites) for targeted delivery. In cancer therapy, recombinant humanized collagen reduces immunogenicity, improving the safety of sustained-release chemotherapeutics.

CHALLENGES: Supply chain vulnerabilities

The extraction and processing of collagen and gelatin proteins is a highly developed process that demands advanced technology. After the edible collagen is derived from the skins of pigs, cows, or fishes, it is filtered and ion-exchanged. Filtration is done using microfiltration technology, where fluid passes through a permeable membrane. Heat sterilization is followed, involving high-temperature heat treatment, and finally drying the product by spray drying technology. The healthcare industry’s reliance on animal-derived raw materials, such as bovine and porcine hides, bones, and tendons, is heavily influenced by livestock health, regulatory frameworks, disease outbreaks (e.g., BSE, swine flu), and agro-economic fluctuations. For example, the Asian outbreak of African Swine Fever (ASF) interfered with the global supply of porcine collagen, causing raw material shortages and price volatility for large Chinese and Southeast Asian producers.

Likewise, geopolitical tensions, logistics disruptions, and border trade regulation have revealed regional supply shortfalls, notably during the COVID-19 crisis. Top manufacturers such as Gelita (Germany) and Nitta Gelatin Inc. (Japan) faced delays and higher transportation costs due to container shortages and port congestion, which delayed timely delivery to pharmaceutical and food-grade collagen customers globally.

Global Collagen & Gelatin Market Ecosystem Analysis

The collagen & gelatin ecosystem consists of several key players, including raw material suppliers, pharmaceutical and biotechnology companies, and regulatory authorities such as the FDA and EMA. These organizations work together to ensure product safety and quality, which influences the approval and commercialization of collagen-based therapeutics and implants. Additionally, hospitals and surgical centers play a significant role in this process. Together, these stakeholders interact and collaborate to drive growth and innovation within the collagen & gelatin industry.

Collagen & Gelatin Market Ecosystem
 

Wound care application to hold largest market share during forecast period

The collagen market is divided by application into orthopedic, wound care, dental, surgical, cardiovascular, and other segments. Of these, the wound care segment is estimated to have the second-highest growth rate during 2024 due to the rising demand for biocompatible and regenerative materials in managing acute and chronic wounds. Collagen dressings are commonly used due to their potential to enhance faster healing, cell proliferation, and tissue regeneration. They effectively treat burns, pressure ulcers, diabetic foot ulcers, and surgical wounds. This development is also bolstered by the rising global population of elderly individuals, who are more susceptible to slow-healing wounds and the increased rate of surgical procedures and trauma.

Healthcare providers are realizing the clinical benefits of collagen-derived wound care products, such as quicker healing times and better patient outcomes. Technological progress, such as composite collagen dressings, bioactive materials, and smart wound care systems, further enhances product performance and therapeutic effectiveness. Increased reimbursement coverage in mature markets and expanding healthcare access in emerging economies accelerate broader adoption. As the healthcare sector advances toward cost-effective wound care therapy, the wound care division is expected to drive significant growth in the collagen industry.

Hospitals end user segment to lead collagen & gelatin market during forecast period

The collagen & gelatin market is segmented by end user into surgical centers and hospitals. Among these, the hospital segment is projected to have the highest growth rate as it implements large-scale cutting-edge therapeutic solutions. These hospitals act as focal points for managing collagen- and gelatin-based products for wound healing, drug delivery devices, surgical fixation, and regenerative therapy that align with pharma and biotech firm-led innovations. Their clinical capabilities, regulatory acceptance, and availability of heterogeneous patient groups make them preferred partners in implementing and testing new biomedical materials.

The use of soft-tissue attachments and bone-graft substitutes (such as DBM and BMP) is increasing across hospitals to reduce the duration of patient stays and enhance the healing process. Bone-graft substitutes are used as osteoconductive and osteoinductive materials, specifically across orthopedic and spinal procedures. Similarly, hemostatic agents and adhesion barriers are increasingly being adopted for abdominal and cardiovascular procedures to prevent post-operative complications. Hospitals have a strategic function in clinical studies and product testing, enabling real-world use and assessment of next-generation collagen-based treatments. Growth in the prevalence of chronic diseases, surgery, and degenerative disorders further drives demand for pharma-grade biomaterials, enabling large-volume use in high-acuity care facilities. Institutional purchasing capacity and demand for FDA- or EMA-cleared biomaterials further guarantee stable demand for high-purity, therapeutic-grade collagen and gelatin.

 

North America to Dominate Collagen & Gelatin Market During Forecast Period

North America has the largest market share, driven by its robust healthcare infrastructure, high R&D spending, and presence of key industry players and research centers. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period, fueled by its fast-growing healthcare market, increasing prevalence of chronic diseases, and growing government efforts toward research promotion.

North America, comprising the US and Canada, dominates the global collagen & gelatin market. Heart disease is the leading cause of death in the US, affecting men and women of various racial and ethnic backgrounds. Approximately 660,000 people die from heart disease annually, accounting for one in every four deaths and equivalent to one person every 40 seconds.

Chronic diseases, such as cardiovascular and neurological diseases, require surgical intervention for treatment. This is an indicator of market growth in the region. Over 50% of Americans have chronic conditions, such as heart disease, stroke, cancer, or diabetes, which are the top reasons for death, disability, and high healthcare costs in the country. Thus, the US is the leading revenue-generating country in this market in North America.

Collagen & Gelatin Market Region
HIGHEST CAGR MARKET IN 2025–2030
US IS THE FASTEST GROWING MARKET IN THE REGION

Recent Developments of Collagen & Gelatin Market

  • In May 2024, the company commercialized its first production batches of PB Leiner’s SOLUGEL premium fish collagen peptides to customers in Asia and the US.
  • In March 2024, Integra Life Sciences received US FDA approval to commercialize a dermal regeneration template for the repair of scar contractures.
  • In February 2024, 3M filed the Form 10 registration statement for the planned spin-off of its healthcare business as the newly independent healthcare company, namely, Solventum.
  • In May 2023, DSM and Firmenich merged to create a new company, DSM-Firmenich, which brings together one of the largest innovation and creation communities in nutrition, health, and beauty.

Key Market Players

Want to explore hidden markets that can drive new revenue in Collagen & Gelatin Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion)
Segments covered Product Type, Source, Application, End User
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Key Questions Addressed by the Report

What are the opportunities for growth in the collagen & gelatin industry?
The expansion of 3D bioprinting for organ and tissue fabrication presents significant growth opportunities for the collagen & gelatin industry.
Which applications dominated the collagen & gelatin market in 2024?
In 2024, the orthopedic application segment held the largest share of the collagen market.
Which product type of the collagen & gelatin market is expected to witness the highest growth during the forecast period?
Collagen is expected to witness the highest growth during the forecast period.
Which end user segment witnessed the highest growth in the collagen and gelatin services market in 2024?
Hospitals are expected to register the highest growth during the forecast period.
What is the projected market size for the collagen & gelatin market during the forecast period?
The global collagen & gelatin market is expected to grow from USD 1,295.5 million in 2025 to USD 1,671.3 million in 2030, at a CAGR of 5.8%.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Collagen & Gelatin Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
26
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
42
PREMIUM INSIGHTS
46
MARKET OVERVIEW
49
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing incidence of diabetes, cancers, and chronic diseases
    - Increasing use in tissue engineering and regenerative medicine
    - Rising demand for advanced wound care products
    - Growing number of surgical procedures
    - Surge in use of collagen as drug delivery system
    RESTRAINTS
    - High manufacturing cost
    - Allergenic & ethical concerns
    OPPORTUNITIES
    - Growing adoption of marine & recombinant collagen
    - Expansion of 3D bioprinting for organ and tissue fabrication
    CHALLENGES
    - Supply chain vulnerabilities
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 COLLAGEN & GELATIN MARKET: ECOSYSTEM ANALYSIS
    PRODUCT PROVIDERS
    END USERS
    REGULATORY BODIES
  • 5.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Extraction technologies
    - Hydrolyzation & purification
    - Recombinant production
    COMPLEMENTARY TECHNOLOGIES
    - 3D scanning & printing
    ADJACENT TECHNOLOGIES
    - Encapsulation
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS
    BUYING CRITERIA
  • 5.11 PATENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.13 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024
    AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY REGION, 2023–2024
  • 5.14 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 350300
    EXPORT DATA HS CODE 350300
  • 5.15 IMPACT OF AI/GEN AI ON COLLAGEN & GELATIN MARKET
  • 5.16 INVESTMENT AND FUNDING SCENARIO
COLLAGEN AND GELATIN MARKET, BY PRODUCT TYPE
83
  • 6.1 INTRODUCTION
  • 6.2 COLLAGEN
    GROWING FOCUS ON REGENERATIVE MEDICINE AND DRUG DELIVERY INNOVATION TO BOOST DEMAND
  • 6.3 GELATIN
    RISING FOCUS ON SOFT AND HARD GELATIN CAPSULES IN ORAL DELIVERY TO DRIVE MARKET
COLLAGEN AND GELATIN MARKET, BY SOURCE
89
  • 7.1 INTRODUCTION
  • 7.2 BOVINE SOURCES
    INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET
  • 7.3 PORCINE SOURCES
    LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND
  • 7.4 OTHER SOURCES
COLLAGEN MARKET, BY APPLICATION
102
  • 8.1 INTRODUCTION
  • 8.2 ORTHOPEDIC
    INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET
  • 8.3 WOUND CARE
    RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION
  • 8.4 DENTAL
    RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET
  • 8.5 SURGICAL
    INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS
  • 8.6 CARDIOVASCULAR
    GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH
  • 8.7 OTHER APPLICATIONS
GELATIN MARKET, BY APPLICATION
116
  • 9.1 INTRODUCTION
  • 9.2 ORTHOPEDIC
    USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET
  • 9.3 WOUND CARE
    APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET
  • 9.4 OTHER APPLICATIONS
COLLAGEN AND GELATIN MARKET, BY END USER
123
  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
    SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS TO DRIVE MARKET
  • 10.3 SURGICAL CENTERS
    AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS TO BOOST DEMAND
COLLAGEN & GELATIN MARKET, BY REGION
132
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Increasing incidence of periodontitis and burn injuries to drive market
    CANADA
    - Growing geriatric population and volume of surgeries to boost collagen and gelatin demand
  • 11.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increase in healthcare expenditure to boost adoption of collagen and gelatin products
    UK
    - High risk of pressure ulcers in diabetic patients to drive market
    FRANCE
    - Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Rising elderly population to support market growth
    CHINA
    - Significant elderly population with diabetes to push demand for collagen and gelatin products
    INDIA
    - Increasing healthcare spending by government to stimulate market growth
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    INCREASING NUMBER OF DIABETIC PATIENTS TO RISE DEMAND FOR COLLAGEN AND GELATIN PRODUCTS
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    GROWING FOCUS ON HEALTHCARE INFRASTRUCTURE IMPROVEMENT TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
185
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLLAGEN & GELATIN MARKET
  • 12.3 REVENUE ANALYSIS, 2020–2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Source footprint
    - Application footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
204
  • 13.1 KEY PLAYERS
    INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SMITH+NEPHEW
    - Business overview
    - Products offered
    - MnM view
    DSM-FIRMENICH
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    NITTA GELATIN INC.
    - Business overview
    - Products offered
    - MnM view
    TESSENDERLO GROUP
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SOLVENTUM
    - Business overview
    - Products offered
    - Recent developments
    MEDTRONIC PLC
    - Business overview
    - Products offered
    COLLPLANT BIOTECHNOLOGIES LTD.
    - Business overview
    - Products offered
    - Recent developments
    ZIMVIE INC.
    - Business overview
    - Products offered
    JELLAGEN
    - Business overview
    - Products offered
    - Recent developments
    COLLAGEN SOLUTIONS PLC
    - Business overview
    - Products offered
    REGENITY
    - Business overview
    - Products offered
    - Recent developments
    SYMATESE LABS
    - Business overview
    - Products offered
    GELITA AG
    - Business overview
    - Products offered
  • 13.2 OTHER PLAYERS
    BICO
    MATRICEL GMBH
    DARLING INGREDIENTS
    WEISHARDT
    HYFINE GELATIN CO., LTD.
    GEISTLICH PHARMA AG
    SYNERHEAL PHARMACEUTICALS
    BIOREGEN TECHNOLOGIES
    MERIL LIFE SCIENCES PVT. LTD.
    MEDSKIN SUWELACK
    COLOGENESIS HEALTHCARE PVT LTD
    DERMARITE INDUSTRIES, LLC
    EUCARE PHARMACEUTICALS PRIVATE LIMITED
APPENDIX
246
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 COLLAGEN & GELATIN MARKET: RISK ANALYSIS
  • TABLE 3 COLLAGEN & GELATIN MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 4 NUMBER OF SURGERIES PERFORMED IN US, 2023–2024
  • TABLE 5 COLLAGEN & GELATIN MARKET: KEY PRODUCT PROVIDERS
  • TABLE 6 COLLAGEN & GELATIN MARKET: KEY END USERS
  • TABLE 7 COLLAGEN & GELATIN MARKET: REGULATORY BODIES
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 COLLAGEN & GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • TABLE 14 KEY PATENTS IN GELATIN MARKET, 2022–2024
  • TABLE 15 KEY PATENTS IN COLLAGEN MARKET, 2022–2024
  • TABLE 16 COLLAGEN & GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025–2026
  • TABLE 17 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024 (USD/KG)
  • TABLE 18 BOVINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON)
  • TABLE 19 PORCINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON)
  • TABLE 20 POULTRY: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON)
  • TABLE 21 MARINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON)
  • TABLE 22 IMPORT VOLUME FOR HS CODE 350300, 2020–2024 (US DOLLAR THOUSAND)
  • TABLE 23 EXPORT VOLUME FOR HS CODE 854330, 2020–2024 (US DOLLAR THOUSAND)
  • TABLE 24 COLLAGEN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 25 COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 EUROPE: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 34 GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 35 BOVINE COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 36 NORTH AMERICA: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 EUROPE: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 BOVINE GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 40 NORTH AMERICA: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 EUROPE: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 PORCINE COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 EUROPE: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 PORCINE GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 48 NORTH AMERICA: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 EUROPE: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 OTHER COLLAGEN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 EUROPE: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 OTHER GELATIN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 60 COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 61 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 70 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 COLLAGEN MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 85 GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 90 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 93 GELATIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 95 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 98 GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 99 HOSPITALS: COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 100 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 101 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 103 HOSPITALS: GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 104 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 105 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 107 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 109 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 111 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 112 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 113 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 115 GLOBAL COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 116 GLOBAL GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 117 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 118 NORTH AMERICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 120 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 121 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 122 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 123 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 125 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 126 NORTH AMERICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 127 US: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 128 US: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 129 US: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 130 US: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 131 US: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 132 US: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 133 US: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 134 CANADA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 CANADA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 136 CANADA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 137 CANADA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 138 CANADA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 139 CANADA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 140 CANADA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 141 EUROPE: KEY MACROINDICATORS
  • TABLE 142 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 143 EUROPE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 144 EUROPE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 145 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 146 EUROPE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 147 EUROPE: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 148 EUROPE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 149 EUROPE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 150 EUROPE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 151 GERMANY: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 GERMANY: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 153 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 154 GERMANY: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 155 GERMANY: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 156 GERMANY: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 157 GERMANY: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 158 UK: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 159 UK: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 160 UK: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 161 UK: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 162 UK: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 163 UK: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 164 UK: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 165 FRANCE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 166 FRANCE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 167 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 168 FRANCE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 169 FRANCE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 170 FRANCE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 171 FRANCE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 172 REST OF EUROPE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 174 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 175 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 176 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 177 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 178 REST OF EUROPE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 180 ASIA PACIFIC: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 189 JAPAN: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 JAPAN: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 191 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 192 JAPAN: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 193 JAPAN: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 194 JAPAN: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 195 JAPAN: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 196 CHINA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 CHINA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 198 CHINA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 199 CHINA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 200 CHINA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 201 CHINA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 202 CHINA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 203 INDIA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 INDIA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 205 INDIA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 206 INDIA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 207 INDIA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 208 INDIA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 209 INDIA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 217 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 218 LATIN AMERICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 219 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 220 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 221 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 222 LATIN AMERICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 223 LATIN AMERICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 224 LATIN AMERICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 226 MIDDLE EAST & AFRICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 233 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COLLAGEN AND GELATIN PLAYERS
  • TABLE 234 COLLAGEN & GELATIN MARKET: DEGREE OF COMPETITION
  • TABLE 235 COLLAGEN & GELATIN MARKET: REGION FOOTPRINT
  • TABLE 236 COLLAGEN & GELATIN MARKET: SOURCE FOOTPRINT
  • TABLE 237 COLLAGEN & GELATIN MARKET: APPLICATION FOOTPRINT
  • TABLE 238 COLLAGEN & GELATIN MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 239 COLLAGEN & GELATIN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 240 COLLAGEN & GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
  • TABLE 241 COLLAGEN & GELATIN MARKET: DEALS, JANUARY 2021– MARCH 2025
  • TABLE 242 COLLAGEN & GELATIN MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 243 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 244 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 245 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 247 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 248 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 249 DSM-FIRMENICH: COMPANY OVERVIEW
  • TABLE 250 DSM–FIRMENICH: PRODUCTS OFFERED
  • TABLE 251 DSM FIRMENICH: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 252 NITTA GELATIN INC.: COMPANY OVERVIEW
  • TABLE 253 NITTA GELATIN INC.: PRODUCTS OFFERED
  • TABLE 254 TESSENDERLO GROUP: COMPANY OVERVIEW
  • TABLE 255 TESSENDERLO GROUP: PRODUCTS OFFERED
  • TABLE 256 TESSENDERLO GROUP: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 257 TESSENDERLO GROUP: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 258 SOLVENTUM: COMPANY OVERVIEW
  • TABLE 259 SOLVENTUM: PRODUCTS OFFERED
  • TABLE 260 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 261 MEDTRONIC PLC: COMPANY OVERVIEW
  • TABLE 262 MEDTRONIC PLC: PRODUCTS OFFERED
  • TABLE 263 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
  • TABLE 264 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS OFFERED
  • TABLE 265 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
  • TABLE 266 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 267 ZIMVIE INC.: COMPANY OVERVIEW
  • TABLE 268 ZIMVIE INC: PRODUCTS OFFERED
  • TABLE 269 JELLAGEN: COMPANY OVERVIEW
  • TABLE 270 JELLAGEN: PRODUCTS OFFERED
  • TABLE 271 JELLAGEN: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 272 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW
  • TABLE 273 COLLAGEN SOLUTIONS PLC: PRODUCTS OFFERED
  • TABLE 274 REGENITY: COMPANY OVERVIEW
  • TABLE 275 REGENITY: PRODUCTS OFFERED
  • TABLE 276 REGENITY: DEALS, JANUARY 2021–MARCH 2025
  • TABLE 277 SYMATESE LABS: COMPANY OVERVIEW
  • TABLE 278 SYMATESE LABS: PRODUCTS OFFERED
  • TABLE 279 GELITA AG: COMPANY OVERVIEW
  • TABLE 280 GELITA AG: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 COLLAGEN & GELATIN MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 COLLAGEN & GELATIN MARKET: RESEARCH DESIGN
  • FIGURE 3 COLLAGEN & GELATIN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 COLLAGEN & GELATIN MARKET: LIST OF PRIMARY PARTICIPANTS
  • FIGURE 5 COLLAGEN & GELATIN MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 6 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 8 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 10 COLLAGEN & GELATIN MARKET: CAGR PROJECTIONS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2025 VS. 2030
  • FIGURE 13 COLLAGEN & GELATIN MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 COLLAGEN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 GELATIN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 COLLAGEN & GELATIN MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 REGIONAL SNAPSHOT OF COLLAGEN & GELATIN MARKET
  • FIGURE 18 RISING DEMAND FOR ADVANCED WOUND CARE PRODUCTS TO DRIVE MARKET
  • FIGURE 19 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN & GELATIN MARKET
  • FIGURE 20 BOVINE SEGMENT TO DOMINATE MARKET IN 2030
  • FIGURE 21 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2024
  • FIGURE 22 CHINA TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2025 TO 2030
  • FIGURE 23 INDIA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET FROM 2025 TO 2030
  • FIGURE 24 COLLAGEN & GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 26 COLLAGEN AND GELATIN VALUE CHAIN
  • FIGURE 27 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
  • FIGURE 30 PATENTS GRANTED FOR GELATIN MARKET, JANUARY 2014–DECEMBER 2024
  • FIGURE 31 PATENTS GRANTED FOR COLLAGEN MARKET, JANUARY 2014–DECEMEBER 2024
  • FIGURE 32 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024 (USD/KG)
  • FIGURE 33 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY REGION, 2023-2024 (USD/TON)
  • FIGURE 34 COLLAGEN & GELATIN MARKET: IMPACT OF AI
  • FIGURE 35 NORTH AMERICA: COLLAGEN & GELATIN MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: COLLAGEN & GELATIN MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN COLLAGEN & GELATIN MARKET, 2020–2024
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COLLAGEN & GELATIN MARKET (2024)
  • FIGURE 39 COLLAGEN & GELATIN MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 40 COLLAGEN & GELATIN MARKET: COMPANY FOOTPRINT
  • FIGURE 41 COLLAGEN & GELATIN MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 42 COMPANY VALUATION & FINANCIAL METRICS OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 COLLAGEN & GELATIN MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46 SMITH+NEPHEW: COMPANY SNAPSHOT
  • FIGURE 47 DSM-FIRMENICH: COMPANY SNAPSHOT
  • FIGURE 48 NITTA GELATIN INC.: COMPANY SNAPSHOT
  • FIGURE 49 TESSENDERLO GROUP: COMPANY SNAPSHOT
  • FIGURE 50 SOLVENTUM: COMPANY SNAPSHOT
  • FIGURE 51 MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 52 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT
  • FIGURE 53 ZIMVIE INC.: COMPANY SNAPSHOT

 

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global collagen & gelatin market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

Secondary Research

The market for the companies offering collagen & gelatin was evaluated by secondary data available through paid and unpaid sources, analyzing the product and service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives. Secondary data was analyzed to determine the overall size of the global collagen & gelatin market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global collagen and gelatin market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, and experts from the supply side, such as C-level and D-level executives and managers. These interviews were conducted across major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). The primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

A breakdown of the primary respondents is given below.

Collagen & Gelatin Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the collagen and gelatin market was estimated and validated through multiple approaches, such as the top-down and bottom-up approaches. These methods were also used extensively to estimate the size of various subsegments in the markets.

Collagen & Gelatin Market

Data Triangulation

After determining the market size from the estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

Collagen is a fibrous structural protein of connective tissue. It is rich in proline and glycine and yields gelatin on hydrolysis. Gelatin is a partially hydrolyzed protein of collagen. Collagen and gelatin are natural biomaterials and are mainly used in wound care and orthopedic applications.

The report covers collagen and gelatin derived from bovine, porcine, and other sources (marine collagen; collagen obtained from chicken, rats, duck, and equine tendons; and recombinant collagen). The report’s scope is restricted to collagen and gelatin end products used for medical applications only. The use of collagen and gelatin as an intermediate product/raw material for pharmaceutical development and manufacturing (to produce hard capsules, softgel capsules, tablet binding or coating, components, or vaccines) and biotechnology applications (such as biomaterials, bioprinting) are not considered in the scope of this report.

Stakeholders

  • Biomaterial manufacturing companies
  • Original equipment manufacturing companies
  • Biomaterial suppliers and distributors
  • Medical research institutes
  • Government bodies
  • Corporate entities
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the collagen & gelatin market based on product type, source, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall collagen & gelatin market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the market size of the segments in four regions: North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategies
  • To study trends & disruptions impacting business; apply pricing analysis, supply/value chain analysis, ecosystem analysis, technology analysis, patent analysis, and trade analysis; and identify key conferences & events in 2025–2026, key stakeholders & buying criteria, and the investment & funding scenario
  • To study the impact of AI/Gen AI on the market under study, along with the macroeconomic outlook for each region.

 

Previous Versions of this Report

Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopaedic, Cardiovascular, Dental, Surgical, Nerve Repair), End User (Hospitals, Surgical Centers), Region - Global Forecast to 2028

Report Code BT 5488
Published in Jul, 2023, By MarketsandMarkets™

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region - Global Forecast to 2026

Report Code BT 5488
Published in Jul, 2021, By MarketsandMarkets™

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region - Global Forecast to 2026

Report Code BT 5488
Published in Aug, 2017, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Collagen & Gelatin Market

DMCA.com Protection Status